Yıl 2015,
Cilt: 36 Sayı: 3, 2307 - 2311, 13.05.2015
Öz
Kaynakça
- George Sgouros, PhD, and Robert F. Hobbs, PhD (2014) Dosimetry for Radiopharmaceutical Therapy Semin Nucl Med 44:172-178 C 2014 Elsevier Inc
- George Sgouros (2008) Alpha-particles for targeted therapy,Advanced Drug Delivery Reviews 60 (2008) © 2008 Elsevier B.V
- Mauro Valente,Francisco Malano,Pedro Pérez(2013) Internal dosimetry for alpha emitters radiopharmaceuticals in biological tissue studied with the FLUKA code, Latin American Symposium on Nuclear Physics and Applications (X LASNPA), December 2013 Montevideo, Uruguay
- Olivier Couturi er, Ste´phane Supiot et.al.( 2005),Cancer radioimmunotherapy with alpha- emitting nuclides European Journal of Nuclear Medicine and Molecular Imaging Vol. 32, No. 5, May 2005
- Richard J. Kowalsky Steven W. Falen, ( 2004) Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine, by the Ame rican Ph armacists Ass ociation. 2004
- Chen-Yu Huang, Susanna Guatelli, Bradley M. Oborn, and Barry J. Allen (2012),Microdosimetry for Targeted Alpha Therapy of Cancer, Hindawi Publishing Corporation, Computational and Mathematical Methods in Medicine,Volume 2012, Article ID 153212,July 2012
- Ruby Meredith, MD, PhD, Barry Wessels, PhD, and Susan Knox, MD, PhD,(2008) Risks to Normal Tissues From Radionuclide Therapy, Semin Nucl Med 38:347-357 © 2008 Elsevier Inc.
Yıl 2015,
Cilt: 36 Sayı: 3, 2307 - 2311, 13.05.2015
Öz
Abstract. Having useful properties in therapeutic radiopharmaceuticals, Radionuclides with alpha emitters plays a significant role in curing cancers. Some properties like short range and deposited energy in unit length of pathway cause to enhance the effect of alpha particle on destroying the DNA of cancer cells. Therefore, recognizing this capacity involves more investigations over the biological effect of these particles on human body. Properties of alpha emitters led to exert profound differences between this field and other fields of nuclear medicine. In order to understand the effect of alpha particles and optimizing the trend of corresponding research, Microdosimetry is considered as an influential tool.
Anahtar Kelimeler
Kaynakça
- George Sgouros, PhD, and Robert F. Hobbs, PhD (2014) Dosimetry for Radiopharmaceutical Therapy Semin Nucl Med 44:172-178 C 2014 Elsevier Inc
- George Sgouros (2008) Alpha-particles for targeted therapy,Advanced Drug Delivery Reviews 60 (2008) © 2008 Elsevier B.V
- Mauro Valente,Francisco Malano,Pedro Pérez(2013) Internal dosimetry for alpha emitters radiopharmaceuticals in biological tissue studied with the FLUKA code, Latin American Symposium on Nuclear Physics and Applications (X LASNPA), December 2013 Montevideo, Uruguay
- Olivier Couturi er, Ste´phane Supiot et.al.( 2005),Cancer radioimmunotherapy with alpha- emitting nuclides European Journal of Nuclear Medicine and Molecular Imaging Vol. 32, No. 5, May 2005
- Richard J. Kowalsky Steven W. Falen, ( 2004) Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine, by the Ame rican Ph armacists Ass ociation. 2004
- Chen-Yu Huang, Susanna Guatelli, Bradley M. Oborn, and Barry J. Allen (2012),Microdosimetry for Targeted Alpha Therapy of Cancer, Hindawi Publishing Corporation, Computational and Mathematical Methods in Medicine,Volume 2012, Article ID 153212,July 2012
- Ruby Meredith, MD, PhD, Barry Wessels, PhD, and Susan Knox, MD, PhD,(2008) Risks to Normal Tissues From Radionuclide Therapy, Semin Nucl Med 38:347-357 © 2008 Elsevier Inc.
Toplam 7 adet kaynakça vardır.
Ayrıntılar
| Bölüm | Derleme |
|---|---|
| Yazarlar | |
| Yayımlanma Tarihi | 13 Mayıs 2015 |
| Yayımlandığı Sayı | Yıl 2015 Cilt: 36 Sayı: 3 |